Long-term diet and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) severityArticle Published on 2022-12-192023-07-10 Journal: The American journal of clinical nutrition [Category] COVID19(2023년), [키워드] alternate healthy eating index COVID-19 severity dietary quality hyperinsulinemia inflammatory diet long-term diet Mediterranean diet Prospective cohort study. SARS-COV-2 infection [DOI] 10.1093/ajcn/nqac219 PMC 바로가기
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19코로나19 중증도에 따라 항체 표적 SARS-CoV-2 에피토프 레퍼토리 달라Article Published on 2022-12-012022-09-11 Journal: Virulence [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] antibodies antibody Antigen association Asymptomatic asymptomatic individual asymptomatic infection Betacoronavirus betacoronavirus Community convalescent correlated COVID-19 COVID-19 severity develop diagnosed diagnostics disease severity domains Epitopes Evidence evidence of finding FIVE five groups HKU1 Hospitalization IgG IgGs Immunity immunogenic immunogenic peptide individual Infection less MERS-CoV nucleocapsid protein Nucleocapsid proteins OC43 participant pathogenic pathogenic mechanisms peptide peptide array peptides pilot study predicted Protein RBDs reaction Receptor binding domain Region repertoire SARS-CoV RBD SARS-CoV RBDs SARS-CoV-2 SARS-CoV-2 epitope SARS-CoV-2 epitopes seroconverted Seroprevalence seroprevalence. severity severity of COVID-19 symptomatic symptomatic COVID-19 symptomatic infection therapeutic therapeutic antibodies Vaccines Viral with COVID-19 without symptoms [DOI] 10.1080/21505594.2022.2073025 PMC 바로가기 [Article Type] Article
Association of trace element status in COVID-19 patients with disease severityResearch article Published on 2022-12-012022-10-05 Journal: Journal of trace elements in medicine and biology [Category] COVID19(2023년), SARS, 변종, [키워드] Anti-inflammatory antioxidant clinical condition clinical symptom conditions coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 severity Critical Cu death died disease severity evaluated Fe four group groups I immune response immune system Infection Mg Mild symptom new SARS-CoV-2 no difference Patient reduce risk SARS-COV-2 infection Se Serum level severity severity of symptoms shown significant difference the patient Trace element trace elements Zn [DOI] 10.1016/j.jtemb.2022.127055 [Article Type] Research article
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyArticle Published on 2022-12-012022-11-15 Journal: Rheumatology International [Category] 바이오마커, 진단, [키워드] Active disease ANCA-associated vasculitis Care clinical manifestations Cohort conducted COVID-19 COVID-19 infection COVID-19 severity Critical cross-sectional Cyclophosphamide death demographic died Disease activity Features Follow-up General population Immunosuppressant increased risk India Infection managing moderate non-COVID-19 patient not differ ocular outcome Patient patients patients died predicted receiving regimen required risk of COVID-19 rituximab SARS-CoV-2. severity single-center Supplemental oxygen therapy the patient Treatment Univariate analysis Vasculitis [DOI] 10.1007/s00296-022-05177-2 PMC 바로가기
SARS-CoV-2 reinfection and COVID-19 severitySARS-CoV-2 재감염 및 COVID-19 심각성Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] antibodies antibody clinical recovery clinical symptom Clinical symptoms coronavirus COVID-19 COVID-19 severity diagnosed early stage episode of Frequency Hospitalization ICU Infection infections negative RT-PCR no difference no differences Patient patients patients with SARS-CoV-2 performed positive positive RT-PCR Reinfection RT-PCR SARS-CoV-2 SARS-CoV-2 positive RT-PCR serology Seven severity Severity of infection Severity. transfer variant was performed were infected Whole genome sequencing [DOI] 10.1080/22221751.2022.2052358 PMC 바로가기 [Article Type] Article
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic healthArticle Published on 2022-12-012022-11-15 Journal: Biochimica et biophysica acta. Molecular basis of [Category] COVID19(2023년), SARS, 진단, [키워드] affected cardiometabolic cardiovascular Cluster Complication country COVID COVID-19 COVID-19 pandemic COVID-19 severity CVD cytokine cytokine production diabetes Final hallmark Health hypertension IL-6 IL10 IL2 IL4 IL8 immune system increased the risk infected patient Inflammation inflammatory state influence molecular molecular. morbidity and mortality obese pathophysiological Patient predictor pro-inflammatory reported resulting SARS-CoV2 systemic damage target type 2 diabete virus [DOI] 10.1016/j.bbadis.2022.166559 PMC 바로가기
The Drosophila melanogaster ACE2 ortholog genes are differently expressed in obesity/diabetes and aging models: Implications for COVID-19 pathologyArticle Published on 2022-12-012022-11-15 Journal: Biochimica et biophysica acta. Molecular basis of [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] ACE2 ACE2 ortholog ACE2 orthologs ACE2 receptor Acer age analyzed Ance animal model approach bind binding affinity complement coronavirus disease COVID-19 COVID-19 pathology COVID-19 severity death dependent on diabetes disorders Drosophila melanogaster Effect elderly ENhance expressed Factors glycoprotein host cells humans increase individual interact Interaction molecular molecular docking mRNA expression obesity ortholog predicted Protein regions regulated Research responsible risk factor Risk factors. robust SARS-CoV-2 SARS-CoV-2 variant shown spike spike-ACE2 susceptible the Spike translational Transmissibility virus [DOI] 10.1016/j.bbadis.2022.166551 PMC 바로가기
Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivorsArticle Published on 2022-11-012022-11-15 Journal: Pain [Category] COVID19(2023년), SARS, 바이오마커, [키워드] Analysis analyzed association Biomarker Clinical data cohort study collected collecting data Comorbidities conducted coronavirus disease COVID-19 COVID-19 severity discharge exhibited Factors First wave Glucose greater hospital Hospital admission hospital discharge hospitalised Hospitalized hospitalized COVID-19 Inflammatory biomarker investigated Lymphocyte count Other outbreak Pain participant Patient Predictive Prevalence serological severity significantly Spain survivor Survivors Symptom Symptoms were assessed with COVID-19 women [DOI] 10.1097/j.pain.0000000000002608 PMC 바로가기
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in QatarArticle Published on 2022-11-012022-11-15 Journal: International Journal of Infectious Diseases [Category] SARS, 진단, [키워드] 95% confidence interval adjusted odds ratio Analysis BA.2 case-control study conducted Control control group controls COVID-19 COVID-19 severity Critical Disease progression drug Effectiveness eligible Epidemiology Evidence fatal COVID-19 food form high-risk patient higher risk incidence individual Mild-to-moderate neutralizing antibody occurred omicron Patient progression protective effect receive reducing SARS-CoV-2 Sotrovimab Sotrovimab. study period Subgroup analysis subgroup of patient Treatment treatment group United State [DOI] 10.1016/j.ijid.2022.09.023 PMC 바로가기
TIGIT Monoallelic Nonsense Variant in Patient with Severe COVID-19 Infection, ThailandArticle Published on 2022-11-012022-11-16 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome cause contribute coronavirus coronavirus disease COVID-19 COVID-19 severity cytokine expression heterozygous immune responses Mutation Nonsense Patient produced respiratory infections resulting SARS SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 severe COVID-19 T cell T cells Thailand TIGIT variant viruses zoonoses zoonoses. [DOI] 10.3201/eid2811.220914 PMC 바로가기